Daré Bioscience Announces Publication in Contraception of Positive Efficacy and Safety Findings from a Pre-Pivotal Postcoital Test Study of Ovaprene®: an Investigational Hormone-Free Monthly Intravaginal Contraceptive

15d ago

DARE

PremiumCompany Announcements

Daré Bioscience’s Reverse Stock Split: Navigating the Risks of Market Perception and Shareholder Liquidity

27d ago

DARE

PremiumPress Releases

Daré Bioscience Reports Full Year 2023 Financial Results and Provides Company Update

29d ago

DARE

PremiumPre-Earnings

Daré Bioscience (DARE) Q4 Earnings Cheat Sheet

1M ago

DARE

PremiumPress Releases

Daré Bioscience to Host Full Year 2023 Financial Results and Company Update Conference Call and Webcast on March 28, 2024

1M ago

DARE

PremiumPress Releases

Daré Bioscience Announces Positive End-of-Phase 2 Meeting with FDA on Development of Sildenafil Cream, 3.6% in Female Sexual Arousal Disorder and Provides Company Focus Areas for 2024

3M ago

DARE

More DARE News >

DARE News on the Web

2024-04-23

Daré Bioscience Announces Grant Funding Installment to Support Further Development of Novel Contraceptive Technology DARE-LARC1

Yahoo Finance

Neutral

2024-04-11

Yahoo Finance

Neutral

2024-04-03

Analysts Are Bullish on These Healthcare Stocks: BiomX (PHGE), Daré Bioscience (DARE)

TipRanks News

Bullish

2024-04-01

Daré Bioscience, Inc. Q4 2023 Earnings Call Transcript

Yahoo Finance

Neutral

2024-03-30

Daré Bioscience’s Reverse Stock Split: Navigating the Risks of Market Perception and Shareholder Liquidity

TipRanks News

Neutral

2024-03-28

DARE Stock Earnings: Dare Bioscience Beats EPS, Beats Revenue for Q4 2023

InvestorPlace

Neutral

2024-03-21

Daré Bioscience to Host Full Year 2023 Financial Results and Company Update Conference Call and Webcast on March 28, 2024

Yahoo Finance

Neutral

2024-03-15

This overlooked corner of women's health could be a $350 billion market opportunity

CNBC

Neutral

News Score - Last 7 Days

Neutral

DARE

Sector Average

Media Buzz

This Week1 articles

Weekly Average1.25 articles

News Sentiment

This Week50%

Sector Average58%

See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is DARE’s Media Buzz Sentiment?

1 articles about DARE were published this week. In an average week, 1.25 articles are published.

What is DARE’s weekly average amount of articles?

In an average week, 1.25 articles about DARE are published.

What is DARE’s News Sentiment?

50% of articles about DARE were positive this week, compared to its sector average of 58%.

Healthcare Stocks that are Trending in the News

DAWNDay One Biopharmaceuticals

TAKTakeda Pharmaceutical Company

NBIXNeurocrine

AMEDAmedisys

MORFMorphic Holding

Showing the stocks with the most bullish news sentiment over the past week

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing